Inquire About a Product| Product: | Docetaxel-d9 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D4555 | ||||||||
| Unlabeled CAS Number: | 114977-28-5 | ||||||||
| Synonyms: | Taxotere-D9 | ||||||||
| Pricing: |
|
||||||||
| Formula: | C43H44NO14D9 | ||||||||
| Enrichment: | 98%D | ||||||||
| Molecular Weight: | 816.93 | ||||||||
| Structure: |
|
||||||||
| Category: | All Inhibitors | ||||||||
| Literature References: |
Araque Arroyo, P., Perez, U., Diez, C., Controversies in the management of adjuvant breast cancer with taxanes: Review of the current literature. Cancer Treatment Reviews, 2011, April, 37 (2): 105–110.; Lyseng-Williamson KA, Fenton C., Docetaxel: a review of its use in metastatic breast cancer. Drugs, 2005, 65 (17): 2513–31. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled anti-mitotic chemotherapy medication. Interferes with cell division. Used to treat locally advanced metastatic breast cancer, head and neck cancer, gastric cancer, hormone-refractory prostate cancer, and non small-cell lung cancer. |